科华生物(002022.SZ)：目前未在电商平台开设店铺

Core Viewpoint - The company is leveraging its strong technical foundation in in vitro diagnostics to establish a solid base for the home testing market, focusing on respiratory, digestive, and reproductive health products [1] Group 1: Company Strategy - The company plans to continuously enrich its product offerings in the home testing sector [1] - The company is integrating digital devices and software to build a personal health management ecosystem [1] - The company employs a dual sales model of direct sales and distribution, and has not yet opened stores on e-commerce platforms [1]